首页 | 本学科首页   官方微博 | 高级检索  
     


Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group
Authors:Villablanca Judith G  London Wendy B  Naranjo Arlene  McGrady Patrick  Ames Matthew M  Reid Joel M  McGovern Renee M  Buhrow Sarah A  Jackson Hollie  Stranzinger Enno  Kitchen Brenda J  Sondel Paul M  Parisi Marguerite T  Shulkin Barry  Yanik Gregory A  Cohn Susan L  Reynolds C Patrick
Affiliation:Children's Hospital Los Angeles, Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California 90027, USA. jvillablanca@chla.usc.edu
Abstract:
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号